Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16531
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorRedwood, Alec-
dc.contributor.authorStrautins, Kaija-
dc.contributor.authorPavlos, Rebecca-
dc.contributor.authorWoolnough, Emily-
dc.contributor.authorChang, Christina C-
dc.contributor.authorPhillips, Elizabeth-
dc.date2016-11-22-
dc.date.accessioned2017-01-18T07:40:12Z-
dc.date.available2017-01-18T07:40:12Z-
dc.date.issued2017-05-
dc.identifier.citationThe Journal of Allergy and Clinical Immunology: In Practice 2017; 5(3): 823-826en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16531-
dc.description.abstractThere are major challenges defining drug causality in cases of severe cutaneous adverse reactions (SCAR) involving multiple antibiotics. We describe a case of toxic epidermal necrolysis (TEN) occurring in the setting of multiple antibiotics and the use of IFN-γ enzyme-linked immunospot assay and flow cytometry to clarify causality.en_US
dc.titleDrug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysisen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe Journal of Allergy and Clinical Immunology: In Practiceen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Parkville, Victoria, Australiaen_US
dc.identifier.affiliationInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australiaen_US
dc.identifier.affiliationDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USAen_US
dc.identifier.affiliationDepartment of Pharmacology, Oates Institute for Experimental Therapeutics, Vanderbilt University Medical School, Nashville, Tennessee, USAen_US
dc.type.studyortrialCase Series and Case Reportsen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27888029en_US
dc.identifier.doi10.1016/j.jaip.2016.09.043en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-5111-6367-
dc.type.austinJournal Articleen_US
local.name.researcherTrubiano, Jason-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Apr 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.